Loading...
Leafly Holdings, Inc.
LFLY•NASDAQ
Healthcare
Medical - Pharmaceuticals
$0.20
$0.03(16.10%)
Leafly Holdings, Inc. (LFLY) Financial Performance & Income Statement Overview
Review Leafly Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-18.01%
↓ 18.01%
Operating Income Growth
55.52%
↑ 55.52%
Net Income Growth
39.49%
↑ 39.49%
Operating Cash Flow Growth
115.40%
↑ 115.40%
Operating Margin
-7.85%
↓ 7.85%
Gross Margin
89.54%
↑ 89.54%
Net Profit Margin
-15.36%
↓ 15.36%
ROE
33.75%
↑ 33.75%
ROIC
15.82%
↑ 15.82%
Leafly Holdings, Inc. (LFLY) Income Statement & Financial Overview
Review Leafly Holdings, Inc.'s (LFLY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $8.52M | $8.35M | $8.72M | $9.05M |
| Cost of Revenue | $838000.00 | $904000.00 | $959000.00 | $976000.00 |
| Gross Profit | $7.68M | $7.45M | $7.76M | $8.07M |
| Gross Profit Ratio | $0.90 | $0.89 | $0.89 | $0.89 |
| R&D Expenses | $2.20M | $2.21M | $2.38M | $2.41M |
| SG&A Expenses | $5.68M | $5.79M | $6.03M | $7.41M |
| Operating Expenses | $7.88M | $8.00M | $8.41M | $9.82M |
| Total Costs & Expenses | $8.71M | $8.90M | $9.37M | $10.80M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $641000.00 | $629000.00 | $638000.00 | $607000.00 |
| Depreciation & Amortization | $396000.00 | $378000.00 | $323000.00 | $329000.00 |
| EBITDA | $91000.00 | -$132000.00 | -$314000.00 | -$1.45M |
| EBITDA Ratio | $0.01 | -$0.02 | -$0.04 | -$0.16 |
| Operating Income | -$195000.00 | -$547000.00 | -$646000.00 | -$1.75M |
| Operating Income Ratio | -$0.02 | -$0.07 | -$0.07 | -$0.19 |
| Other Income/Expenses (Net) | -$751000.00 | -$592000.00 | -$629000.00 | -$639000.00 |
| Income Before Tax | -$946000.00 | -$1.14M | -$1.27M | -$2.39M |
| Income Before Tax Ratio | -$0.11 | -$0.14 | -$0.15 | -$0.26 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $285724.00 |
| Net Income | -$946000.00 | -$1.14M | -$1.27M | -$2.39M |
| Net Income Ratio | -$0.11 | -$0.14 | -$0.15 | -$0.26 |
| EPS | -$0.38 | -$0.46 | -$0.55 | -$1.09 |
| Diluted EPS | -$0.38 | -$0.46 | -$0.55 | -$1.09 |
| Weighted Avg Shares Outstanding | $2.50M | $2.50M | $2.33M | $2.20M |
| Weighted Avg Shares Outstanding (Diluted) | $2.50M | $2.50M | $2.33M | $2.20M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan